View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Polatuzumab Vedotin 1.8 / Mosunetuzumab 60, diffuse large B-Non-Hodgkin Lymphoma, cycle 2
Protocol-ID: 2813 V1.0 (Mini), POLVED1.8/MOSU60, DLBCL, C2Indication(s)
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.03.2025